Exenatide was the first GLP-1 receptor agonist approved by the FDA for the treatment of type 2 diabetes in 2005
This structural change improves metabolic stability and alters the peptides interaction with melanocortin receptors
Enzymes called methyltransferases catalyze this process, using SAMe as a methyl donor
With a healthy lifestyle, results can be long lasting
Delivering 1,000 mg per day, this supplement may help support lipid levels already within normal range as part of your daily routine.* With quick-release capsules and a formula free from unnecessary additives, its a simple way to incorporate this trusted botanical into your wellness regimen.*
Metabolic syndrome is a cluster of conditions-increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol or triglyceride levels-that occur together, increasing your risk of heart disease, stroke, and type 2 diabetes